Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab
Alector Inc. (NASDAQ:ALEC) is one of the best stocks under $3 to invest in.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 3,332,835 | $7,165,596 | +41% | 0% |
| 2. | 683 Capital Partners Ari Zweiman | 3,200,000 | $6,880,000 | -5% | 0.36% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 2,935,253 | $6,310,794 | -11% | 0.01% |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,815,983 | $6,054,363 | 0.22% | |
| 5. | Spruce Street Capital Alex Rosen And Simon Basseyn | 2,101,068 | $4,517,296 | +88% | 1.09% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 20,000 | $500,000.00 | 44,621 | 2020-02-03 | Filing | |
| $19.00 | 203,200 | $3,860,800.00 | 203,200 | 2019-02-11 | Filing | |
| $19.00 | 50,561 | $960,659.00 | 2,455,853 | 2019-02-11 | Filing | |
| $19.00 | 157,939 | $3,000,841.00 | 10,434,976 | 2019-02-11 | Filing | |
| $19.00 | 203,200 | $3,860,800.00 | 203,200 | 2019-02-11 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.97 | 87,216 | $172,190.55 | 2,367,206 | 2026-06-02 | Filing | |
| $1.88 | 3,475 | $6,542.73 | 95,461 | 2026-06-03 | Filing | |
| $1.97 | 5,709 | $11,270.71 | 98,936 | 2026-06-02 | Filing | |
| $1.97 | 19,360 | $38,220.51 | 379,900 | 2026-06-02 | Filing | |
| $2.65 | 1,820 | $4,823.00 | 104,645 | 2026-04-16 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,000,000 | $21,500,000 | 0.62% | |
| 2. | 7,741,245 | $16,643,677 | 0% | |
| 3. | 3,887,200 | $8,357,480 | 3.53% | |
| 4. | 3,678,722 | $7,909,252 | 0% | |
| 5. | 3,545,719 | $7,623,297 | 2.18% |